Clinical Trials · NCT00103376
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Medical University of South Carolina
- Enrollment
- 23
- Start date
- Oct 2004
- Locations
- 4 sites, United States
- Primary endpoint
- Prostate-specific Antigen (PSA) Response